Gobind S Gill, Sujith Baliga, Jacqueline Lewy, Benjamin V Bajaj, Sara L Gallotto, Aibhlin Fitzpatrick, Brooke Patteson, Samantha Speroni, Allison Omsberg, Paul Caruso, Otto Rapalino, Patricia Musolino, Torunn I Yock
{"title":"探究接受质子放射治疗的儿科患者的放射诱发莫亚莫亚综合征与放射剂量之间的关系:质子射线治疗后儿科患者的莫亚莫亚综合征。","authors":"Gobind S Gill, Sujith Baliga, Jacqueline Lewy, Benjamin V Bajaj, Sara L Gallotto, Aibhlin Fitzpatrick, Brooke Patteson, Samantha Speroni, Allison Omsberg, Paul Caruso, Otto Rapalino, Patricia Musolino, Torunn I Yock","doi":"10.1016/j.ijrobp.2024.11.070","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The incidence and risk factors associated with radiation-induced Moya-Moya Syndrome (RIMMS) in pediatric brain tumor patients treated with proton radiotherapy (PRT) remain poorly understood. The objective of this study was to determine the incidence of RIMMS in the setting of CNS proton radiotherapy (PRT) in a pediatric cohort and assess its relationship with dose to the Circle of Willis (COW) or optic chiasm (OC).</p><p><strong>Methods & materials: </strong>We performed a retrospective review of pediatric brain tumor patient treated with intracranial PRT (1995-2021). The exposure of interest was mean dose to the optic chiasm due to close proximity to the COW vasculature. Wilcoxon rank-sum test was used to determine the association between OC dose and RIMMS. Univariable logistic regression modeling was used to determine the odds of developing RIMMS based on a cutpoint of 52Gy.</p><p><strong>Results: </strong>Of 676 patients, 14 developed RIMMS, with a median onset of 1.9 years. The cumulative incidence of RIMMS at 8 years was 2.4%. Patients with RIMMS had higher mean OC dose than those without (51.5 Gy vs 23.7 Gy, p<0.0001). Univariable logistic regression showed patients with an OC dose > 52 Gy had increased RIMMS risk compared to those with dose < 52 Gy (OR = 9.9, p<0.001).</p><p><strong>Conclusions: </strong>The incidence of RIMMS remains low in our primarily proton-treated pediatric cohort with a cumulative incidence of 2.4% over 8 years and is similar to photon-treated cohorts. Development of RIMMS was associated with higher doses to the COW and OC.</p>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":" ","pages":""},"PeriodicalIF":6.4000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exploring the Relationship Between Radiation-Induced Moya Moya Syndrome and Radiation Dose for Pediatric Patients Treated with Proton Radiation Therapy: Moya Moya in Peds Patients After Proton RT.\",\"authors\":\"Gobind S Gill, Sujith Baliga, Jacqueline Lewy, Benjamin V Bajaj, Sara L Gallotto, Aibhlin Fitzpatrick, Brooke Patteson, Samantha Speroni, Allison Omsberg, Paul Caruso, Otto Rapalino, Patricia Musolino, Torunn I Yock\",\"doi\":\"10.1016/j.ijrobp.2024.11.070\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The incidence and risk factors associated with radiation-induced Moya-Moya Syndrome (RIMMS) in pediatric brain tumor patients treated with proton radiotherapy (PRT) remain poorly understood. The objective of this study was to determine the incidence of RIMMS in the setting of CNS proton radiotherapy (PRT) in a pediatric cohort and assess its relationship with dose to the Circle of Willis (COW) or optic chiasm (OC).</p><p><strong>Methods & materials: </strong>We performed a retrospective review of pediatric brain tumor patient treated with intracranial PRT (1995-2021). The exposure of interest was mean dose to the optic chiasm due to close proximity to the COW vasculature. Wilcoxon rank-sum test was used to determine the association between OC dose and RIMMS. Univariable logistic regression modeling was used to determine the odds of developing RIMMS based on a cutpoint of 52Gy.</p><p><strong>Results: </strong>Of 676 patients, 14 developed RIMMS, with a median onset of 1.9 years. The cumulative incidence of RIMMS at 8 years was 2.4%. Patients with RIMMS had higher mean OC dose than those without (51.5 Gy vs 23.7 Gy, p<0.0001). Univariable logistic regression showed patients with an OC dose > 52 Gy had increased RIMMS risk compared to those with dose < 52 Gy (OR = 9.9, p<0.001).</p><p><strong>Conclusions: </strong>The incidence of RIMMS remains low in our primarily proton-treated pediatric cohort with a cumulative incidence of 2.4% over 8 years and is similar to photon-treated cohorts. Development of RIMMS was associated with higher doses to the COW and OC.</p>\",\"PeriodicalId\":14215,\"journal\":{\"name\":\"International Journal of Radiation Oncology Biology Physics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.4000,\"publicationDate\":\"2024-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Oncology Biology Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijrobp.2024.11.070\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2024.11.070","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Exploring the Relationship Between Radiation-Induced Moya Moya Syndrome and Radiation Dose for Pediatric Patients Treated with Proton Radiation Therapy: Moya Moya in Peds Patients After Proton RT.
Purpose: The incidence and risk factors associated with radiation-induced Moya-Moya Syndrome (RIMMS) in pediatric brain tumor patients treated with proton radiotherapy (PRT) remain poorly understood. The objective of this study was to determine the incidence of RIMMS in the setting of CNS proton radiotherapy (PRT) in a pediatric cohort and assess its relationship with dose to the Circle of Willis (COW) or optic chiasm (OC).
Methods & materials: We performed a retrospective review of pediatric brain tumor patient treated with intracranial PRT (1995-2021). The exposure of interest was mean dose to the optic chiasm due to close proximity to the COW vasculature. Wilcoxon rank-sum test was used to determine the association between OC dose and RIMMS. Univariable logistic regression modeling was used to determine the odds of developing RIMMS based on a cutpoint of 52Gy.
Results: Of 676 patients, 14 developed RIMMS, with a median onset of 1.9 years. The cumulative incidence of RIMMS at 8 years was 2.4%. Patients with RIMMS had higher mean OC dose than those without (51.5 Gy vs 23.7 Gy, p<0.0001). Univariable logistic regression showed patients with an OC dose > 52 Gy had increased RIMMS risk compared to those with dose < 52 Gy (OR = 9.9, p<0.001).
Conclusions: The incidence of RIMMS remains low in our primarily proton-treated pediatric cohort with a cumulative incidence of 2.4% over 8 years and is similar to photon-treated cohorts. Development of RIMMS was associated with higher doses to the COW and OC.
期刊介绍:
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.